Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis.

Biological Psychiatry
James M StonePhilip K McGuire

Abstract

Animal models of psychosis propose that striatal hyperdopaminergia is driven by abnormalities in hippocampal glutamatergic neurotransmission, but this has never been tested in humans. Sixteen individuals with an at-risk mental state for psychosis (ARMS) and 12 control subjects underwent proton magnetic resonance spectroscopy to estimate hippocampal glutamate and [18F]DOPA positron emission tomography to index striatal dopamine function. The relationship between hippocampal glutamate and striatal dopamine, as well as their relationship with prodromal symptoms, was determined using linear regression. In ARMS subjects, but not controls, there was a significant negative relationship between hippocampal glutamate levels and striatal [18F]DOPA uptake (p = .03). Within the ARMS sample, striatal [18F]DOPA uptake was correlated with severity of abnormal beliefs (p = .03), there was a trend for hippocampal glutamate levels to be correlated with disordered speech (p = .06) and a trend for the interaction between hippocampal glutamate and [18F]DOPA uptake to predict later transition to psychosis (p = .07). The relationship between hippocampal glutamate and striatal dopamine systems is altered in people at high risk of psychosis, and the de...Continue Reading

References

Dec 2, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Daniel J Lodge, Anthony A Grace
Jan 12, 2008·Trends in Pharmacological Sciences·Philip McGuirePaolo Fusar-Poli
Jan 7, 2009·Archives of General Psychiatry·Oliver D HowesPaul M Grasby
Sep 1, 2009·Behavioural Brain Research·Daniel J Lodge, Anthony A Grace

❮ Previous
Next ❯

Citations

Apr 5, 2012·Archives of General Psychiatry·Oliver D HowesShitij Kapur
Oct 31, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·N KoutsoulerisW Maier
Apr 22, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Camilo de la Fuente-SandovalAriel Graff-Guerrero
Apr 25, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yijuan Du, Anthony A Grace
Jul 9, 2011·PloS One·Fabiana da Silva AlvesTherese van Amelsvoort
Jan 7, 2014·Trends in Neurosciences·Toby T Winton-BrownOliver D Howes
Sep 13, 2014·Current Behavioral Neuroscience Reports·Alexandra D ForrestSteven J Siegel
Jul 26, 2012·ISRN Pharmacology·Kyra-Verena SendtDerek K Tracy
Jul 17, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Joseph KambeitzOliver D Howes
Jan 3, 2015·Trends in Neurosciences·Gemma ModinosPhilip McGuire
Sep 10, 2013·Child and Adolescent Psychiatric Clinics of North America·Sandra M GouldingElaine F Walker
Jul 9, 2013·Biological Psychiatry·Lisa-Marie GreenwoodNadia Solowij
Apr 26, 2011·Biological Psychiatry·Heike Tost, Andreas Meyer-Lindenberg
Apr 13, 2011·Biological Psychiatry·Oswald J N BloemenThérèse A M J van Amelsvoort
Nov 3, 2015·The Lancet. Psychiatry·Philip McGuireAndre Zugman
Jan 5, 2011·CNS Neuroscience & Therapeutics·Jussi Hirvonen, Jarmo Hietala
Jun 20, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Igor NenadicStefan Smesny
Sep 14, 2015·The International Journal of Neuropsychopharmacology·Camilo de la Fuente-SandovalDikoma C Shungu
Aug 6, 2011·Biological Psychiatry·Yael PiontkewitzIna Weiner
Jul 11, 2014·Brain Structure & Function·Tobias GleichJürgen Gallinat
Apr 5, 2016·NeuroImage·George GiffordPhilip McGuire
Mar 5, 2016·Current Opinion in Behavioral Sciences·Gary GilmourMark E Walton
May 23, 2015·Development and Psychopathology·Matcheri S KeshavanJai L Shah
Nov 10, 2012·European Psychiatry : the Journal of the Association of European Psychiatrists·P Fusar-PoliP K McGuire
May 18, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Oswald J N BloemenThérèse A M J van Amelsvoort
Sep 4, 2012·Neurochemistry International·Ana P HerrmannElaine Elisabetsky
Jun 22, 2012·The International Journal of Neuropsychopharmacology·Camilo de la Fuente-SandovalAriel Graff-Guerrero
Oct 11, 2016·Biological Psychiatry·Oliver D HowesRobin M Murray
Feb 9, 2012·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Philip McGuireOliver Howes
Jan 15, 2015·Journal of Psychopharmacology·Oliver HowesJames Stone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.